---
title: "Organovo (Nasdaq: ONVO) gives business update on its focus in developing treatments for inflammatory bowel disease."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233457407.md"
description: "In San Diego on March 27, 2025, Organovo Holdings, Inc. (Nasdaq: ONVO) shared a business update. The company, a clinical stage biotech firm, specializing in innovative treatments for inflammatory bowel disease (IBD), detailed their recent developments."
datetime: "2025-03-27T12:27:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233457407.md)
  - [en](https://longbridge.com/en/news/233457407.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233457407.md)
---

# Organovo (Nasdaq: ONVO) gives business update on its focus in developing treatments for inflammatory bowel disease.

In San Diego on March 27, 2025, Organovo Holdings, Inc. (Nasdaq: ONVO) shared a business update. The company, a clinical stage biotech firm, specializing in innovative treatments for inflammatory bowel disease (IBD), detailed their recent developments.

### Related Stocks

- [ONVO.US](https://longbridge.com/en/quote/ONVO.US.md)

## Related News & Research

- [Dana Logsdon Roofing and Solar Expands Integrated Whole-Home Protection Services Across San Diego County](https://longbridge.com/en/news/295238981.md)
- [OSR Health clarifies Nasdaq has not approved shareholder loyalty CVR program](https://longbridge.com/en/news/295502117.md)
- [12:15 ETInventHelp Inventor Develops New Tractor Trailer Step (SBT-2298)](https://longbridge.com/en/news/295957049.md)
- [06:03 ETAdvance America Unveils 2 New Southern California Locations in Santa Ana and San Diego](https://longbridge.com/en/news/295388341.md)
- [Clene Inc. (NASDAQ:CLNN) Receives Average Recommendation of "Moderate Buy" from Analysts](https://longbridge.com/en/news/295521365.md)